Free Trial

Price T Rowe Associates Inc. MD Makes New $1 Million Investment in Red Violet, Inc. (NASDAQ:RDVT)

Red Violet logo with Computer and Technology background

Price T Rowe Associates Inc. MD purchased a new stake in shares of Red Violet, Inc. (NASDAQ:RDVT - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 27,677 shares of the company's stock, valued at approximately $1,002,000. Price T Rowe Associates Inc. MD owned approximately 0.20% of Red Violet at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Quantbot Technologies LP purchased a new position in shares of Red Violet during the 4th quarter valued at $88,000. Wells Fargo & Company MN grew its position in Red Violet by 58.0% during the fourth quarter. Wells Fargo & Company MN now owns 5,688 shares of the company's stock worth $206,000 after buying an additional 2,089 shares in the last quarter. Franklin Resources Inc. bought a new position in Red Violet in the 4th quarter worth about $207,000. Hsbc Holdings PLC bought a new position in Red Violet in the 4th quarter worth about $215,000. Finally, Hennion & Walsh Asset Management Inc. purchased a new stake in shares of Red Violet in the 4th quarter valued at about $232,000. 63.56% of the stock is currently owned by hedge funds and other institutional investors.

Red Violet Trading Up 0.5%

Shares of NASDAQ RDVT traded up $0.26 during midday trading on Thursday, hitting $49.46. 36,863 shares of the company's stock were exchanged, compared to its average volume of 96,141. The business's fifty day moving average price is $38.34 and its two-hundred day moving average price is $37.23. The company has a market cap of $690.28 million, a price-to-earnings ratio of 137.57 and a beta of 1.69. Red Violet, Inc. has a 12-month low of $19.60 and a 12-month high of $49.80.

Insiders Place Their Bets

In related news, insider Jeffrey Alan Dell sold 5,000 shares of the stock in a transaction on Friday, May 9th. The stock was sold at an average price of $46.20, for a total value of $231,000.00. Following the transaction, the insider now owns 172,968 shares of the company's stock, valued at $7,991,121.60. This represents a 2.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Derek Dubner sold 10,000 shares of Red Violet stock in a transaction dated Friday, May 9th. The stock was sold at an average price of $46.21, for a total value of $462,100.00. Following the sale, the chief executive officer now directly owns 580,379 shares of the company's stock, valued at approximately $26,819,313.59. This trade represents a 1.69% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 25,000 shares of company stock valued at $1,082,400 in the last quarter. Corporate insiders own 9.50% of the company's stock.

About Red Violet

(Free Report)

Red Violet, Inc, a software and services company, specializes in proprietary technologies and applying analytical capabilities to deliver identity intelligence in the United States. It offers idiCORE, an investigative solution used to address various organizational challenges, which include due diligence, risk mitigation, identity authentication, fraud detection and prevention, customer acquisition, and regulatory compliance; and FOREWARN, an app-based solution that provides instant knowledge before face-to-face engagement with a consumer, as well as helps professionals to identify and mitigate risk.

Further Reading

Institutional Ownership by Quarter for Red Violet (NASDAQ:RDVT)

Should You Invest $1,000 in Red Violet Right Now?

Before you consider Red Violet, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Red Violet wasn't on the list.

While Red Violet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines